Ondansetron: A selective 5HT3 receptor antagonist and it advances in drug delivery system
Crossref DOI link: https://doi.org/10.30574/wjarr.2022.16.3.1275
Published Online: 2022-12-30
Update policy: https://doi.org/10.30574/wjarr.ourcrossmarkpolicy
Supriya Subhas Jana,
Mrunmayi Deepak Lad,
Suranya Subramanian,
Dhanashree Prakash Sanap,
